『WTR Biotech Spotlight』のカバーアート

WTR Biotech Spotlight

WTR Biotech Spotlight

著者: Joe Brunetto
無料で聴く

このコンテンツについて

WTR Biotech Spotlight is a biweekly conversation with biotech executives, medical experts, and investors on recent clinical data or industry-driving events in biotech.

© 2025 WTR Biotech Spotlight
個人ファイナンス 経済学
エピソード
  • Current State of Biotech, Market Pressure Points, Obesity and PD-1/VEGF
    2025/05/08

    Tim Gerdeman and Do Kim discuss the current state of biotech, what brought us here, and how the rest of year may look for the group. They also review recent market-shaping events in the obesity space and progress of the Keytruda-busting PD-1/VEGF bispecifics.

    続きを読む 一部表示
    19 分
  • WTR Biotech Flashcast: Neuroscience, Alzheimer’s and Biogen IOC
    2025/04/24

    On this week's episode of WTR Biotech Spotlight, Tim Gerdeman and Robert Sassoon sit down for a quick flashcast to review Robert's last three reports; Neuroscience, Alzheimer’s and Biogen IOC.

    続きを読む 一部表示
    16 分
  • Annovis Bio's CEO Discusses the promise of Buntanetap in Redefining the Treatment of Alzheimer's and Parkinson's and Next Steps
    2025/03/19

    Founding CEO and President of Annovis Bio (NYSE: ANVS) Dr Maria Maccecchini joins WTR's Tim Gerdeman and Robert Sassoon in this week's WTR Biotech Spotlight episode. Annovis is a late clinical-stage drug platform company developing novel disease-modifying therapies for neurodegenerative diseases, to include targeting Alzheimer's and Parkinson's, as well as other related diseases. Dr Maccecchini discusses the company's lead drug candidate Buntanetap and its promise as a treatment that can go beyond simply slowing the rate of cognitive decline in Alzheimer's and Parkinson's patients.

    続きを読む 一部表示
    18 分

WTR Biotech Spotlightに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。